retatrutide companies Eli Lilly and Company's triple agonist, retatrutide, successful in two additional phase 3 obesity trials, delivering significant improvements in weight and A1C Retatrutide Triple Agonist (GLP-1/GIP/GCG) |
Pay in 4 interest-free payments of $5.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

















:max_bytes(150000):strip_icc()/not-eating-signs-symptoms-5201896_final-c41f6a10844343059195cfb13e561098.jpg)






